Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Coya Therapeutics, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 per share | 8.8K | $63.2K | $7.19 | Nov 14, 2024 | Direct |
Coya Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 70.6K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
COYA | Coya Therapeutics, Inc. | Nov 14, 2024 | 1 | $12.9K | 4 | Nov 14, 2024 | Chief Financial Officer |
COYA | Coya Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Chief Financial Officer |
COYA | Coya Therapeutics, Inc. | Feb 2, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Chief Financial Officer |
COYA | Coya Therapeutics, Inc. | Feb 27, 2023 | 1 | $0 | 4 | Mar 1, 2023 | Chief Financial Officer |
COYA | Coya Therapeutics, Inc. | Jan 3, 2023 | 2 | $0 | 4 | Jan 4, 2023 | Chief Financial Officer |
COYA | Coya Therapeutics, Inc. | Dec 28, 2022 | 0 | $0 | 3 | Dec 28, 2022 | Chief Financial Officer |